PRIMARY STUDY
Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study
Key Findings: Both clozapine and ziprasidone appear beneficial in the treatment of cannabis use disorders in patients with schizophrenia.
Type of Study: Clinical Trial
Study Sample Size: 30
Study Result: Positive
Research Location(s): Germany
Year of Pub: 2014
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Citation: Schnell T, et al. Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study. Am J Addict. 2014; 23:308-12. doi: 10.1111/j.1521-0391.2014.12126.x
Authors: Schnell T, Koethe D, Krasnianski A, Gairing S, Schnell K, Daumann J, Gouzoulis-Mayfrank E
